Open letter to Dr Robert Califf, FDA Commissioner: I wish to better understand the decision-making process within the FDA that authorized Moderna’s booster vaccine to be shipped despite serious manufacturing and quality issues?

Dear Dr Califf, This is an open letter in follow-up to a question I have submitted to the FDA’s Center for Biologics Evaluation and Research (CBER). The question is repeated…

Continue ReadingOpen letter to Dr Robert Califf, FDA Commissioner: I wish to better understand the decision-making process within the FDA that authorized Moderna’s booster vaccine to be shipped despite serious manufacturing and quality issues?

Open letter to Professor Cooke, interim co-chair at UKs MHRA: Should the need for a product recall of the AstraZeneca SARS-CoV-2 sterile injectables be investigated by the Defective Medicines Report Centre?

Bridgend, South Wales, 6th June 2024: Hedley Rees, managing director at PharmaFlow, a 21st century consultancy in biopharmaceutical value chain management, calls for MHRA to investigate if AstraZeneca must instigate…

Continue ReadingOpen letter to Professor Cooke, interim co-chair at UKs MHRA: Should the need for a product recall of the AstraZeneca SARS-CoV-2 sterile injectables be investigated by the Defective Medicines Report Centre?

PRESS RELEASE: Dr Shona Lang Brings Preclinical Evidence Synthesis and Systematic Review to PharmaFlow

Bridgend, South Wales, 24th June 2021:  PharmaFlow, a 21st century consultancy in biopharmaceutical value-chains, is pleased to announce that Dr Shona Lang will bring Preclinical Evidence Synthesis and Systematic Review…

Continue ReadingPRESS RELEASE: Dr Shona Lang Brings Preclinical Evidence Synthesis and Systematic Review to PharmaFlow